Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

USING EMPIRIC SATURATION MUTAGENESIS TO IDENTIFY NOVEL ENV TRIMERS FOR VACCINES

By Enthusiast Inc MDFebruary 15, 2017

…We used a novel saturation mutagenesis approach, EMPIRIC (Exceedingly Meticulous and Parallel Investigation of Randomized Individual Codons) to investigate effects of the CD4 binding loop on trimer structure and identify…

291 – Impact of Vaccine-Elicited CD8+ T-Cells on SIV Dynamics

By Jimmy He PharmD, DScMarch 31, 2026

Background Enhancing immune-mediated clearance of latently infected cells is a key strategy to achieving an HIV cure. Here we evaluated CD8+ T cell responses to a potent vaccine regimen administered…

INTACT PROVIRUSES FROM NAIVE AND EFFECTOR MEMORY T CELLS MATCH PERSISTENT VIREMIA

By Jimmy He PharmD, DScApril 28, 2020

…sites is important for future eradication strategies. Near full-length proviral sequences were obtained from naïve (NV), central (CM), transitional (TM) and effector memory (EM) CD4+ T cells (sorted based on…

459 – Tri-Specific Killer Engagers in Macaques Potently Induce NK Cell Responses in Blood and Tissues

By Jimmy He PharmD, DScMarch 20, 2025

…in vivo dose-response study to evaluate TriKE safety and impact on NK cell responses. Methods TriKE was administered subcutaneously 5 times per week for 3 weeks in 3 uninfected RMs,…

HIV-1 Exploits CD169 to Evade IFNα-Induced Antiviral State in Myeloid Cells

By Enthusiast Inc MDFebruary 27, 2015

…fusion was measured by the conventional Vpr-BlaM assay. To investigate if CD169+ myeloid cells are productively infected in vivo, lymph nodes (LNs) from pigtailed macaques chronically infected with RT-SHIVmne027 were…

516 – Anatomical Sites in FIND 2.0 Decedents Harbor Compartmentalized, Transcriptionally Intact HIV-1 Env

By Jimmy He PharmD, DScMarch 20, 2025

…envelope glycoprotein (env) from this cohort. Methods Full length HIV-1 env was PCR amplified from extracted DNA from bone marrow aspirate (BM) and trephine (BMT), brain, bronchoalveolar lavage (BAL), cervicovaginal lavage, kidney,…

498 – Anti-IL-10/Anti-PD-1 Dual Blockade Leads to IFN-Related HIV Elite Control Signatures

By Jimmy He PharmD, DScMarch 20, 2025

…Methods In this study, flow cytometry, cytokine array, and single-cell RNA-Seq/ATAC-Seq were conducted on SIV-infected, virologically suppressed rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1 antibodies (combo-treatment) before analytical treatment…

389 – Methamphetamine Use Disorder in ART PWH Is Associated With Elevated NLRP3 Inflammasome Activation

By Jimmy He PharmD, DScMarch 20, 2025

…Here, we performed single cell analyses to determine signaling pathways by which MA induces immune dysfunction, potentially driving viral transcription in PWH even during ART suppression. Methods Longitudinal inguinal lymph…

SINGLE-CELL PROTEOGENOMIC PROFILING OF HIV-1 RESERVOIR CELLS

By Jimmy He PharmD, DScMarch 24, 2023

…next-generation sequencing approach for the direct ex vivo phenotypic profiling of individual HIV-1 infected memory CD4 (mCD4) T cells from peripheral blood (PB) and lymph nodes (LN) of people living…

VIRAL AND IMMUNE PREDICTORS OF TIME TO VIRAL REBOUND IN SHIV-INFECTED INFANT MACAQUES

By Jimmy He PharmD, DScApril 4, 2022

…2 wpi (Intermediate, n=10), or 8 wpi (Late, n=10). Analytical treatment interruption (ATI) was performed after 1 yr. Peripheral blood (PB), lymph nodes (LN), and rectal biopsies (RB) were collected…

←1
23456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172
…7374757677…
7879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top